Drug helps reprogram macrophage immune cells, suppress prost

A novel therapy that reprograms immune cells to promote antitumor activity helped shrink hard-to-treat prostate and bladder cancers in mice, according to new research.

Related Keywords

United States , Johns Hopkins University , Maryland , American , Robertd Leone , Kennethm Adusei , Jonathan Powell , Barbara Slusher , Xiaoxu Wang , Liang Zhao , Ada Tam Srinivasan Yegnasubramanian , Alexj Lee , Debebe Theodros , Karaa Lombardo , Thomasr Nirschl , Edwardj Pearce , Monali Praharaj , Jelani Zarif , Roberte Meyerhoff , Alokk Singh , Raekwona Williams , Elizabetha Thompson , Lauraa Sena , Johns Hopkins , National Institutes Of Health Cancer Institute , Cancer Immunology Research , American Association For Cancer Research , Bloomberg , Maryland Cigarette Restitution Fund , Dracen Pharmaceuticals , Prostate Cancer Foundation Young Investigator Award , Kimmel Institute For Cancer Immunotherapy , Bloomberg Kimmel Institute For Cancer Immunotherapy , American Association , Endowed Professor , Johns Hopkins Drug Discovery , Kimmel Institute , Yifan Shen , Ada Tam , Srinivasan Yegnasubramanian , Jesse Alt , Rana Rais , National Institutes , National Cancer Institute ,